Treatment Development Program Impact Report

Dec 29, 2022

We look upon 2022 as among the most pivotal years in the history of both the National Alopecia Areata Foundation and the community we serve, as this report illustrates.

2022 was the year our research efforts came to fruition with the first FDA-approved treatment for alopecia areata. Read the story of how it happened. This special Treatment Development Program Impact Report celebrates 12 years of NAAF research efforts which our community helped make possible. https://www.naaf.org/sites/default/files/documents/pdf/final_naaf_impact...

Recent Survey Study Results
NAAF Adds Two New Board Members